Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)
Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)
Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)
Submitted by
admin
on February 27, 2010 - 12:44pm
Source:
Medical News Today
News Tags:
Forrest
Bystolic
heart failure
Headline:
Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)
Do Not Allow Advertisers to Use My Personal information
